Advanced search
Add to list

DAS28 is a robust measure of the physician's clinical judgment of response infliximab therapy

Author
Organization

Citation

Please use this url to cite or link to this publication:

MLA
Vander Cruyssen, Bert, Stijn Van Looy, Bart Wyns, et al. “DAS28 Is a Robust Measure of the Physician’s Clinical Judgment of Response Infliximab Therapy.” Arthritis and Rheumatism. Vol. 52. WILEY-LISS, 2005. 414. Print.
APA
Vander Cruyssen, Bert, Van Looy, S., Wyns, B., WESTHOVENS, R., DUREZ, P., VAN DEN BOSH, F., Veys, E., et al. (2005). DAS28 is a robust measure of the physician’s clinical judgment of response infliximab therapy. ARTHRITIS AND RHEUMATISM (Vol. 52, p. 414). WILEY-LISS.
Chicago author-date
Vander Cruyssen, Bert, Stijn Van Looy, Bart Wyns, R WESTHOVENS, P DUREZ, F VAN DEN BOSH, Eric Veys, et al. 2005. “DAS28 Is a Robust Measure of the Physician’s Clinical Judgment of Response Infliximab Therapy.” In Arthritis and Rheumatism, 52:414. WILEY-LISS.
Chicago author-date (all authors)
Vander Cruyssen, Bert, Stijn Van Looy, Bart Wyns, R WESTHOVENS, P DUREZ, F VAN DEN BOSH, Eric Veys, Herman Mielants, Liselotte De Clerck, A PERETZ, M MALAISE, L VERBRUGGEN, N VASTESAEGER, A GELDHOF, Luc Boullart, and Filip De Keyser. 2005. “DAS28 Is a Robust Measure of the Physician’s Clinical Judgment of Response Infliximab Therapy.” In Arthritis and Rheumatism, 52:414. WILEY-LISS.
Vancouver
1.
Vander Cruyssen B, Van Looy S, Wyns B, WESTHOVENS R, DUREZ P, VAN DEN BOSH F, et al. DAS28 is a robust measure of the physician’s clinical judgment of response infliximab therapy. ARTHRITIS AND RHEUMATISM. WILEY-LISS; 2005. p. 414.
IEEE
[1]
B. Vander Cruyssen et al., “DAS28 is a robust measure of the physician’s clinical judgment of response infliximab therapy,” in ARTHRITIS AND RHEUMATISM, 2005, vol. 52, no. 9, p. 414.
@inproceedings{350558,
  author       = {{Vander Cruyssen, Bert and Van Looy, Stijn and Wyns, Bart and WESTHOVENS, R and DUREZ, P and VAN DEN BOSH, F and Veys, Eric and Mielants, Herman and De Clerck, Liselotte and PERETZ, A and MALAISE, M and VERBRUGGEN, L and VASTESAEGER, N and GELDHOF, A and Boullart, Luc and De Keyser, Filip}},
  booktitle    = {{ARTHRITIS AND RHEUMATISM}},
  issn         = {{0004-3591}},
  language     = {{eng}},
  number       = {{9}},
  pages        = {{S414-S415}},
  publisher    = {{WILEY-LISS}},
  title        = {{DAS28 is a robust measure of the physician's clinical judgment of response infliximab therapy}},
  volume       = {{52}},
  year         = {{2005}},
}

Web of Science
Times cited: